Torrent Pharma acquires Zyg Pharma
Torrent Pharmaceuticals Ltd completed acquisition of the city-based Zyg Pharma Ltd for an undisclosed amount, the Ahmedabad-based drug major said on Saturday.In a regulatory filing to the Bombay Stock Exchange (BSE), Torrent said it had on Friday transacted the entire (100 percent) equity stake of Zyg Pharma in accordance with the share purchase agreement signed on May 5."Terms and conditions...
Login or Register to read the full article
Torrent Pharmaceuticals Ltd completed acquisition of the city-based Zyg Pharma Ltd for an undisclosed amount, the Ahmedabad-based drug major said on Saturday.
In a regulatory filing to the Bombay Stock Exchange (BSE), Torrent said it had on Friday transacted the entire (100 percent) equity stake of Zyg Pharma in accordance with the share purchase agreement signed on May 5.
"Terms and conditions of the agreement have been satisfied and the entire equity was transferred to the company on July 17," Torrent said in its filing.
The Rs.4,200-crore firm said the acquisition was funded through internal accruals.
Encore group's Zyg Pharma is engaged in manufacturing creams, ointments, gels, lotions and solutions.
Promoted by the Merchant family, the 50-year-old Zyg Pharma has also a manufacturing facility at Pithampur near Indore.
"In line with its strategy to diversify into new therapy segments, the acquisition will help Torrent to strengthen its position in niche dermatological segment in the developed markets like the US and Europe," Zyg said in a statement here.
As a flagship company of the Torrent group, the drug maker has plants at Indrad in Gujarat, Baddi in Himachal Pradesh and Sikkim to produce bulk drugs and formulations for domestic and export markets.Torrent Pharmaceuticals operates in more than 50 countries with over 1000 product registrations globally through its 7 fully owned subsidiares
In a regulatory filing to the Bombay Stock Exchange (BSE), Torrent said it had on Friday transacted the entire (100 percent) equity stake of Zyg Pharma in accordance with the share purchase agreement signed on May 5.
"Terms and conditions of the agreement have been satisfied and the entire equity was transferred to the company on July 17," Torrent said in its filing.
The Rs.4,200-crore firm said the acquisition was funded through internal accruals.
Encore group's Zyg Pharma is engaged in manufacturing creams, ointments, gels, lotions and solutions.
Promoted by the Merchant family, the 50-year-old Zyg Pharma has also a manufacturing facility at Pithampur near Indore.
"In line with its strategy to diversify into new therapy segments, the acquisition will help Torrent to strengthen its position in niche dermatological segment in the developed markets like the US and Europe," Zyg said in a statement here.
As a flagship company of the Torrent group, the drug maker has plants at Indrad in Gujarat, Baddi in Himachal Pradesh and Sikkim to produce bulk drugs and formulations for domestic and export markets.Torrent Pharmaceuticals operates in more than 50 countries with over 1000 product registrations globally through its 7 fully owned subsidiares
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd